Stepped care targeting psychological distress in head and neck and lung cancer patients: a randomized clinical trial

BMC Cancer

Anne-Marie H Krebber¹  C René Leemans¹  Remco de Bree¹  Annemieke van Straten⁶  Filip Smit⁴  Egbert F Smit⁵  Annemarie Becker⁵  Guus M Eeckhout²  Aartjan TF Beekman²  Pim Cuijpers⁶  Irma M Verdonck-de Leeuw³ 

[1] Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, Amsterdam, the Netherlands

[2] Department of Psychiatry, VU University Medical Center, Amsterdam, the Netherlands

[3] Department of Otolaryngology / Head and Neck Surgery, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, The Netherlands

[4] Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands

[5] Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, the Netherlands

[6] Department of Clinical Psychology, VU University, Amsterdam, the Netherlands

关键词: Efficacy;    Quality of life;    Screening;    Stepped care;    Psychosocial care;    Depression;    Anxiety;    Distress;    Cancer;   

Others  :  1080434
DOI  :  10.1186/1471-2407-12-173

 received in 2012-01-31, accepted in 2012-05-03,  发布年份 2012

【 摘 要 】

Background

Psychological distress is common in cancer survivors. Although there is some evidence on effectiveness of psychosocial care in distressed cancer patients, referral rate is low. Lack of adequate screening instruments in oncology settings and insufficient availability of traditional models of psychosocial care are the main barriers. A stepped care approach has the potential to improve the efficiency of psychosocial care. The aim of the study described herein is to evaluate efficacy of a stepped care strategy targeting psychological distress in cancer survivors.

Methods/design

The study is designed as a randomized clinical trial with 2 treatment arms: a stepped care intervention programme versus care as usual. Patients treated for head and neck cancer (HNC) or lung cancer (LC) are screened for distress using OncoQuest, a computerized touchscreen system. After stratification for tumour (HNC vs. LC) and stage (stage I/II vs. III/IV), 176 distressed patients are randomly assigned to the intervention or control group. Patients in the intervention group will follow a stepped care model with 4 evidence based steps: 1. Watchful waiting, 2. Guided self-help via Internet or a booklet, 3. Problem Solving Treatment administered by a specialized nurse, and 4. Specialized psychological intervention or antidepressant medication. In the control group, patients receive care as usual which most often is a single interview or referral to specialized intervention. Primary outcome is the Hospital Anxiety and Depression Scale (HADS). Secondary outcome measures are a clinical level of depression or anxiety (CIDI), quality of life (EQ-5D, EORTC QLQ-C30, QLQ-HN35, QLQ-LC13), patient satisfaction with care (EORTC QLQ-PATSAT), and costs (health care utilization and work loss (TIC-P and PRODISQ modules)). Outcomes are evaluated before and after intervention and at 3, 6, 9 and 12 months after intervention.

Discussion

Stepped care is a system of delivering and monitoring treatments, such that effective, yet least resource-intensive, treatment is delivered to patients first. The main aim of a stepped care approach is to simplify the patient pathway, provide access to more patients and to improve patient well-being and cost reduction by directing, where appropriate, patients to low cost (self-)management before high cost specialist services.

Trial registration

NTR1868

【 授权许可】

   
2012 Krebber et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Comprehensive Cancer Centre The Netherlands (IKNL): Netherlands Cancer Registry. Incidence of head and neck cancer and lung cancer. [http://cijfersoverkanker.nl/selecties/Dataset_1/img4f134ef001b62] webcite. 2011. Ref Type: Online Source
• [2]Hopwood P, Stephens RJ: Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 2000, 18:893-903.
• [3]Hutton JM, Williams M: An investigation of psychological distress in patients who have been treated for head and neck cancer. Br J Oral Maxillofac Surg 2001, 39:333-339.
• [4]Rolke HB, Bakke PS, Gallefoss F: Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer. Respir Med 2008, 102:1460-1467.
• [5]de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA: Long-term quality of life of patients with head and neck cancer. Laryngoscope 2000, 110:98-106.
• [6]Hammerlid E, Ahlner-Elmqvist M, Bjordal K, Biorklund A, Evensen J, Boysen M, et al.: A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. Br J Cancer 1999, 80:766-774.
• [7]Bjordal K, Kaasa S: Psychological distress in head and neck cancer patients 7–11 years after curative treatment. Br J Cancer 1995, 71:592-597.
• [8]Karnell LH, Funk GF, Christensen AJ, Rosenthal EL, Magnuson JS: Persistent posttreatment depressive symptoms in patients with head and neck cancer. Head Neck 2006, 28:453-461.
• [9]Verdonck-de Leeuw IM, Eerenstein SE, Van der Linden MH, Kuik DJ, de Bree R, Leemans CR: Distress in spouses and patients after treatment for head and neck cancer. Laryngoscope 2007, 117:238-241.
• [10]Fulcher CD, Badger T, Gunter AK, Marrs JA, Reese JM: Putting evidence into practice: interventions for depression. Clin J Oncol Nurs 2008, 12:131-140.
• [11]Osborn RL, Demoncada AC, Feuerstein M: Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatr Med 2006, 36:13-34.
• [12]Lepore SJ, Coyne JC: Psychological interventions for distress in cancer patients: a review of reviews. Ann Behav Med 2006, 32:85-92.
• [13]Rodin G: Treatment of depression in patients with cancer. Lancet 2008, 372:8-10.
• [14]Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, et al.: High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004, 90:2297-2304.
• [15]Verdonck-de Leeuw IM, de Bree R, Keizer AL, Houffelaar T, Cuijpers P, van der Linden MH, et al.: Computerized prospective screening for high levels of emotional distress in head and neck cancer patients and referral rate to psychosocial care. Oral Oncol 2009, 45:e129-e133.
• [16]Carlson LE, Bultz BD: Efficacy and medical cost offset of psychosocial interventions in cancer care: making the case for economic analyses. Psychooncology 2004, 13:837-849.
• [17]Bower P, Gilbody S: Stepped care in psychological therapies: access, effectiveness and efficiency. Narrative literature review. Br J Psychiatry 2005, 186:11-17.
• [18]Spijker J, Bijl RV, De Graaf R, Nolen WA: Care utilization and outcome of DSM-III-R major depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand 2001, 104:19-24.
• [19]van Straten A, Cuijpers P, Smits N: Effectiveness of a web-based self-help intervention for symptoms of depression, anxiety, and stress: randomized controlled trial. J Med Internet Res 2008, 10:e7.
• [20]Cuijpers P, van Straten A, Warmerdam L: Problem solving therapies for depression: a meta-analysis. Eur Psychiatr 2007, 22:9-15.
• [21]Spek V, Cuijpers P, Nyklicek I, Riper H, Keyzer J, Pop V: Internet-based cognitive behaviour therapy for symptoms of depression and anxiety: a meta-analysis. Psychol Med 2007, 37:319-328.
• [22]Mynors-Wallis L, Davies I, Gray A, Barbour F, Gath D: A randomised controlled trial and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care. Br J Psychiatry 1997, 170:113-119.
• [23]Mynors-Wallis LM, Gath DH, Day A, Baker F: Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000, 320:26-30.
• [24]Strong V, Waters R, Hibberd C, Murray G, Wall L, Walker J, et al.: Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet 2008, 372:40-48.
• [25]Catalan J, Gath DH, Anastasiades P, Bond SA, Day A, Hall L: Evaluation of a brief psychological treatment for emotional disorders in primary care. Psychol Med 1991, 21:1013-1018.
• [26]Hegel MT, Imming J, Cyr-Provost M: Role of behavioral health professionals in a collaborative stepped care treatment model for depression in primary care: project IMPACT. Fam Syst Health 2002, 20:265-277.
• [27]Hegel MT, Oxman TE, Hull JG, Swain K, Swick H: Watchful waiting for minor depression in primary care: remission rates and predictors of improvement. Gen Hosp Psychiatr 2006, 28:205-212.
• [28]Mynors-Wallis LM, Gath DH, Lloyd-Thomas AR, Tomlinson D: Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995, 310:441-445.
• [29]Katz MR, Kopek N, Waldron J, Devins GM, Tomlinson G: Screening for depression in head and neck cancer. Psychooncology 2004, 13:269-280.
• [30]Walker J, Postma K, McHugh GS, Rush R, Coyle B, Strong V, et al.: Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res 2007, 63:83-91.
• [31]Vodermaier A, Linden W, Siu C: Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Canc Inst 2009, 101:1464-1488.
• [32]Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM: A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997, 27:363-370.
• [33]European Organisation for Research and Treatment of Cancer. [http://groups.eortc.be/qol/questionnaires_qlqc30.htm] webcite. 2009. Ref Type: Online Source
• [34]Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de GA, Boysen M, Evensen JF, et al.: Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999, 17:1008-1019.
• [35]Bredart A, Bottomley A, Blazeby JM, Conroy T, Coens C, D'Haese S, et al.: An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32). Eur J Cancer 2005, 41:2120-2131.
• [36]Brooks R: EuroQol: the current state of play. Health Pol 1996, 37:53-72.
• [37]Group EuroQol: Euroqol - a new facility for the measurement of health related quality of life. Health Pol 1990, 16:199-208.
• [38]van Roijen LH, van SA, Al M, Rutten F, Donker M: Cost-utility of brief psychological treatment for depression and anxiety. Br J Psychiatry 2006, 188:323-329.
• [39]Oostenbrink JB, Bouwmans CAM, Koopmanschap MA: Manual for Costing: Methods and standard costs for economic evaluations in health care. Diemen: Health Insurance Board; 2004. Ref Type: Report
• [40]Oostenbrink JB, Meerding WJ, Evers S, et al.: PRODISQ. PROductivity and DISease Questionnaire. Rotterdam/Maastricht; 2004. Ref Type: Report
• [41]Piccirillo JF: Impact of comorbidity and symptoms on the prognosis of patients with oral carcinoma. Arch Otolaryngol Head Neck Surg 2000, 126:1086-1088.
• [42]World Health Organisation: Composite International Diagnostic Interview (CIDI) (version 1.0). Geneva: WHO; 1990.
• [43]Wittchen HU: Reliability and validity studies of the WHO–Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994, 28:57-84.
• [44]Oostenbrink J: Standardisation of costs: the Dutch Manual for Costing in economic evaluations. PharmacoEconomics 2002, 20(7):443-454. Ref Type: Report
• [45]Langley PC: The November 1995 revised Australian guidelines for the economic evaluation of pharmaceuticals. PharmacoEconomics 1996, 9:341-352.
• [46]Torrance GW, Blaker D, Detsky A, Kennedy W, Schubert F, Menon D, et al.: Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics. PharmacoEconomics 1996, 9:535-559.
• [47]Brouwer WB, Koopmanschap MA, Rutten FF: Productivity losses without absence: measurement validation and empirical evidence. Health Pol 1999, 48:13-27.
• [48]van Hout BA, Al MJ, Gordon GS, Rutten FF: Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 1994, 3:309-319.
• [49]van Straten A, Geraedts A, Verdonck-de Leeuw I, Andersson G, Cuijpers P: Psychological treatment of depressive symptoms in patients with medical disorders: a meta-analysis. J Psychosom Res 2010, 69:23-32.
• [50]Jacobsen PB: Screening for psychological distress in cancer patients: challenges and opportunities. J Clin Oncol 2007, 25:4526-4527.
• [51]Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE: Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer 2008, 113:870-878.
• [52]Valderas JM, Alonso J, Guyatt GH: Measuring patient-reported outcomes: moving from clinical trials into clinical practice. Med J Aust 2008, 189:93-94.
• [53]Snyder CF, Aaronson NK: Use of patient-reported outcomes in clinical practice. Lancet 2009, 374:369-370.
• [54]Luckett T, Butow PN, King MT: Improving patient outcomes through the routine use of patient-reported data in cancer clinics: future directions. Psychooncology 2009, 18:1129-1138.
• [55]McLachlan SA, Allenby A, Matthews J, Wirth A, Kissane D, Bishop M, et al.: Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer. J Clin Oncol 2001, 19:4117-4125.
• [56]Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK: Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 2002, 288:3027-3034.
• [57]Velikova G, Brown JM, Smith AB, Selby PJ: Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology. Br J Cancer 2002, 86:51-59.
• [58]Coleman K, Austin BT, Brach C, Wagner EH: Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood ) 2009, 28:75-85.
• [59]van den Brink JL, Moorman PW, de Boer MF, Hop WC, Pruyn JF, Verwoerd CD, et al.: Impact on quality of life of a telemedicine system supporting head and neck cancer patients: a controlled trial during the postoperative period at home. J Am Med Inform Assoc 2007, 14:198-205.
• [60]Ouwens MM, Hermens RR, Hulscher MM, Merkx MA, van den Hoogen FJ, Grol RP, et al.: Impact of an integrated care program for patients with head and neck cancer on the quality of care. Head Neck 2009, 31:902-910.
• [61]Fillion L, de SM, Cook S, Goupil RL, Bairati I, Doll R: Professional patient navigation in head and neck cancer. Semin Oncol Nurs 2009, 25:212-221.
• [62]de Bree R, Verdonck-de Leeuw IM, Keizer AL, Houffelaar A, Leemans CR: Touch screen computer-assisted health-related quality of life and distress data collection in head and neck cancer patients. Clin Otolaryngol 2008, 33:138-142.
• [63]CBO NWHHT: Nation-wide Guideline Laryngeal cancer, version 3.0. 2010. Ref Type: Report
• [64]CBO NVALT: Nation-wide Guideline Lung cancer, version 1.0. 2004. Ref Type: Report
• [65]CBO NWHHT: Nation-wide Guideline Oral Cavity and Oropharyngeal Cancer, version 1.4. 2004. Ref Type: Report
• [66]CBO NWHHT: Nation-wide Guideline Hypopharyngeal Cancer, version 2.0. 2010. Ref Type: Report